Certain information (as indicated by "[*]") has been redacted from this Exhibit in accordance with Item 601(a)(6) of Regulation S-K. CLENE INC. EMPLOYMENT AGREEMENTEmployment Agreement • February 2nd, 2022 • Clene Inc. • Pharmaceutical preparations • Delaware
This Employment Agreement (this “Agreement”) is made and entered into on February 1, 2022 (the “Effective Date”) by and between Clene Inc., a Delaware corporation (the “Company”) and Morgan Brown (“Executive”). The Company and Executive are hereinafter collectively referred to as the “Parties,” and individually referred to as a “Party.”
AMENDMENT TO EMPLOYMENT AGREEMENTEmployment Agreement • February 2nd, 2022 • Clene Inc. • Pharmaceutical preparations • Delaware
This Amendment to Employment Agreement (the “Amendment””) is made effective as of February 1, 2022, by and among Clene Inc., a Delaware corporation (“Company”), and Robert Glanzman (“Executive”). The Company and Executive are sometimes separately referred to herein as a “Party” and are collectively referred to herein as the “Parties”.
RETENTION AND SEPARATION AGREEMENT AND GENERAL RELEASERetention and Separation Agreement and General Release • February 2nd, 2022 • Clene Inc. • Pharmaceutical preparations • Delaware
This Retention and Separation Agreement and General Release (“Agreement”) is entered into as of February 1, 2022 (the “Effective Date”), by and between Clene Inc., a Delaware corporation, on behalf of itself and its subsidiaries and affiliates (“Employer”) and Tae Heum (Ted) Jeong, his heirs, executors, administrators, successors, and assigns (collectively referred to as “Employee”) (collectively with Employer, the “Parties”).
